Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,674 | 350 | 98.9% |
| Education | $62.68 | 9 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $852.91 | 57 | $0 (2024) |
| ABBVIE INC. | $689.74 | 44 | $0 (2024) |
| Amgen Inc. | $681.53 | 45 | $0 (2024) |
| PFIZER INC. | $489.27 | 34 | $0 (2024) |
| Lilly USA, LLC | $401.24 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $361.19 | 17 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $321.99 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $258.11 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $208.65 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $160.44 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,091 | 54 | AstraZeneca Pharmaceuticals LP ($210.47) |
| 2023 | $894.67 | 51 | AbbVie Inc. ($345.90) |
| 2022 | $571.60 | 37 | ABBVIE INC. ($138.46) |
| 2021 | $494.31 | 30 | Novo Nordisk Inc ($71.51) |
| 2020 | $554.49 | 36 | Novo Nordisk Inc ($81.18) |
| 2019 | $534.97 | 36 | Amgen Inc. ($130.10) |
| 2018 | $681.09 | 49 | Novo Nordisk Inc ($150.58) |
| 2017 | $914.19 | 66 | Boehringer Ingelheim Pharmaceuticals, Inc. ($161.92) |
All Payment Transactions
359 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.76 | General |
| 11/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: Endocrinology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.17 | General |
| Category: Biological | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Respiratory | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Inflammation | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Obesity | ||||||
| 08/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Respiratory | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Bone Health | ||||||
| 08/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.88 | General |
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Diabetes Care | ||||||
| 06/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Obesity | ||||||
| 06/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: PAIN | ||||||
| 06/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,480 | 2,312 | $489,637 | $138,187 |
| 2022 | 30 | 1,961 | 2,950 | $632,191 | $178,988 |
| 2021 | 23 | 1,579 | 2,306 | $597,324 | $169,482 |
| 2020 | 24 | 1,818 | 2,461 | $615,908 | $149,957 |
All Medicare Procedures & Services
96 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 392 | 692 | $210,416 | $54,343 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 314 | 314 | $112,412 | $38,885 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 173 | 213 | $43,878 | $11,358 | 25.9% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 25 | 200 | $29,400 | $7,281 | 24.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 25 | 184 | $35,512 | $6,803 | 19.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $10,516 | $3,549 | 33.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 292 | 411 | $4,030 | $3,357 | 83.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $7,854 | $2,748 | 35.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 20 | 20 | $6,560 | $2,458 | 37.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 16 | 17 | $7,888 | $2,231 | 28.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 28 | $4,228 | $1,101 | 26.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 19 | $5,776 | $1,065 | 18.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 38 | 54 | $2,106 | $779.76 | 37.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 20 | 20 | $2,400 | $769.68 | 32.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 14 | 14 | $2,884 | $703.90 | 24.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,500 | $511.55 | 34.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 48 | $384.00 | $105.60 | 27.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $871.00 | $101.43 | 11.6% |
| 90471 | Administration of vaccine | Office | 2023 | 14 | 14 | $1,022 | $36.85 | 3.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 404 | 875 | $266,000 | $69,486 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 300 | 300 | $107,067 | $38,401 | 35.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 158 | 160 | $26,080 | $10,872 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 132 | 154 | $31,724 | $8,413 | 26.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 23 | 23 | $15,226 | $6,401 | 42.0% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 25 | 150 | $22,050 | $5,779 | 26.2% |
About David Cyr
David Cyr is a Family Medicine healthcare provider based in Portsmouth, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598705618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Cyr has received a total of $5,736 in payments from pharmaceutical and medical device companies, with $1,091 received in 2024. These payments were reported across 359 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,674).
As a Medicare-enrolled provider, Cyr has provided services to 6,838 Medicare beneficiaries, totaling 10,029 services with total Medicare billing of $636,613. Data is available for 4 years (2020–2023), covering 96 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Emergency Medicine
- Location Portsmouth, VA
- Active Since 06/07/2006
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598705618
Products in Payments
- UBRELVY (Drug) $403.40
- Ozempic (Drug) $283.94
- JARDIANCE (Drug) $227.03
- AIRSUPRA (Drug) $210.47
- QULIPTA (Drug) $209.75
- Aimovig (Biological) $192.02
- Otezla (Drug) $167.33
- TRELEGY ELLIPTA (Drug) $166.68
- Victoza (Drug) $161.88
- VRAYLAR (Drug) $146.68
- NURTEC ODT (Drug) $145.19
- Prolia (Biological) $141.99
- ENTRESTO (Drug) $141.05
- CHANTIX (Drug) $133.39
- MOUNJARO (Drug) $125.16
- EMGALITY (Drug) $110.19
- JANUVIA (Drug) $105.19
- STIOLTO (Drug) $104.81
- Repatha (Biological) $101.08
- TRULICITY (Drug) $94.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Portsmouth
Dr. Mark Ballentyne, Md, MD
Family Medicine — Payments: $146,131
Dr. M. Lauter, M.d, M.D
Family Medicine — Payments: $25,035
Dr. Roy Adams, D.o, D.O
Family Medicine — Payments: $9,437
Dr. Leonard Otworth, D.o, D.O
Family Medicine — Payments: $5,839
Phillip Roberts, Do, DO
Family Medicine — Payments: $4,247
Dr. Banu Myneni, D.o, D.O
Family Medicine — Payments: $3,876